Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Alzheimer's disease: the challenge of the second century.

Holtzman DM, Morris JC, Goate AM.

Sci Transl Med. 2011 Apr 6;3(77):77sr1. doi: 10.1126/scitranslmed.3002369. Review.

PMID:
21471435
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Novel disease-modifying therapies for Alzheimer's disease.

Jiang T, Yu JT, Tan L.

J Alzheimers Dis. 2012;31(3):475-92. doi: 10.3233/JAD-2012-120640. Review.

PMID:
22669013
[PubMed - indexed for MEDLINE]
3.

Synapses and Alzheimer's disease.

Sheng M, Sabatini BL, Südhof TC.

Cold Spring Harb Perspect Biol. 2012 May 1;4(5). pii: a005777. doi: 10.1101/cshperspect.a005777. Review.

PMID:
22491782
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The study of Golgi apparatus in Alzheimer's disease.

Hu Z, Zeng L, Huang Z, Zhang J, Li T.

Neurochem Res. 2007 Aug;32(8):1265-77. Epub 2007 Mar 31. Review.

PMID:
17401657
[PubMed - indexed for MEDLINE]
5.

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease.

Perrin RJ, Fagan AM, Holtzman DM.

Nature. 2009 Oct 15;461(7266):916-22. doi: 10.1038/nature08538. Review.

PMID:
19829371
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease.

Bateman RJ, Klunk WE.

Neurotherapeutics. 2008 Jul;5(3):381-90. doi: 10.1016/j.nurt.2008.05.009. Review.

PMID:
18625449
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation.

Lin LF, Luo HM.

Neurosci Bull. 2011 Feb;27(1):53-60. doi: 10.1007/s12264-011-1040-6. Review.

PMID:
21270904
[PubMed - indexed for MEDLINE]
8.

A century of Alzheimer's disease.

Goedert M, Spillantini MG.

Science. 2006 Nov 3;314(5800):777-81. Review.

PMID:
17082447
[PubMed - indexed for MEDLINE]
9.

Targeting Abeta and tau in Alzheimer's disease, an early interim report.

Golde TE, Petrucelli L, Lewis J.

Exp Neurol. 2010 Jun;223(2):252-66. doi: 10.1016/j.expneurol.2009.07.035. Epub 2009 Aug 27. Review.

PMID:
19716367
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Progress in the development of new drugs in Alzheimer's disease.

Piau A, Nourhashémi F, Hein C, Caillaud C, Vellas B.

J Nutr Health Aging. 2011 Jan;15(1):45-57.

PMID:
21267520
[PubMed - indexed for MEDLINE]
11.

Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade.

Belkacemi A, Ramassamy C.

Free Radic Biol Med. 2012 Feb 1;52(3):593-600. doi: 10.1016/j.freeradbiomed.2011.11.020. Epub 2011 Dec 8. Review.

PMID:
22172527
[PubMed - indexed for MEDLINE]
12.

Dementia: Alzheimer pathology and vascular factors: from mutually exclusive to interaction.

van Norden AG, van Dijk EJ, de Laat KF, Scheltens P, Olderikkert MG, de Leeuw FE.

Biochim Biophys Acta. 2012 Mar;1822(3):340-9. doi: 10.1016/j.bbadis.2011.07.003. Epub 2011 Jul 14.

PMID:
21777675
[PubMed - indexed for MEDLINE]
Free Article
13.

Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.

Ittner LM, Götz J.

Nat Rev Neurosci. 2011 Feb;12(2):65-72. doi: 10.1038/nrn2967. Epub 2010 Dec 31. Review.

PMID:
21193853
[PubMed - indexed for MEDLINE]
14.

Future targeted disease modifying drugs for Alzheimer's disease.

Dash SK.

Recent Pat CNS Drug Discov. 2011 Jan;6(1):65-76. Review.

PMID:
21073430
[PubMed - indexed for MEDLINE]
15.
16.

Alzheimer's disease.

Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E.

Lancet. 2011 Mar 19;377(9770):1019-31. doi: 10.1016/S0140-6736(10)61349-9. Epub 2011 Mar 1. Review.

PMID:
21371747
[PubMed - indexed for MEDLINE]
17.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
[PubMed - indexed for MEDLINE]
18.

Does Alzheimer's disease begin in the brainstem?

Simic G, Stanic G, Mladinov M, Jovanov-Milosevic N, Kostovic I, Hof PR.

Neuropathol Appl Neurobiol. 2009 Dec;35(6):532-54. doi: 10.1111/j.1365-2990.2009.01038.x. Epub 2009 Aug 4.

PMID:
19682326
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.

Hampel H, Mitchell A, Blennow K, Frank RA, Brettschneider S, Weller L, Möller HJ.

J Neural Transm. 2004 Mar;111(3):247-72. Epub 2003 Dec 3. Review.

PMID:
14991453
[PubMed - indexed for MEDLINE]
20.

Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.

Prvulovic D, Hampel H.

Clin Chem Lab Med. 2011 Mar;49(3):367-74. doi: 10.1515/CCLM.2011.087. Epub 2011 Feb 23. Review.

PMID:
21342022
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk